Embecta

Embecta EV/EBITDA

The EV/EBITDA (Enterprise Value to EBITDA) of Embecta (EMBC) as of Nov 21, 2026 is 5.30. In the previous year, EV/EBITDA (Enterprise Value to EBITDA) was 10.80 — a change of -50.93% (lower).

EV/EBITDA

5.30

YoY

-50.93%

Last updated:

EV/EBITDA (Enterprise Value to EBITDA) of Embecta is 2025 5.30 . EV/EBITDA (Enterprise Value to EBITDA) of Embecta was 2024 10.80 . It decreases by -50.93% lower compared to the previous year.

The Embecta EV/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBITDA
Date
EV/EBITDA
Jan 1, 2019
1.08 USD
Jan 1, 2020
1.12 USD
Jan 1, 2021
1.11 USD
Jan 1, 2022
4.90 USD
Jan 1, 2023
8.07 USD
Jan 1, 2024
10.80 USD
Jan 1, 2025
5.30 USD
The Embecta EV/EBITDA history
YEAREV/EBITDAYoY
5.30-50.93%
10.80+33.86%
8.07+64.60%
4.90+343.08%
1.11-1.18%
1.12+4.03%
1.08—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Embecta Stock analysis

What does Embecta do? Embecta Corp. generates revenue through the manufacturing and distribution of medical devices for diabetes treatment, including pen needles, syringes, and safety injection devices. Its product portfolio features sterile, single-use pen needles designed for use with insulin pens, safety pen needles with dual-end shields to prevent needlestick injuries, and sterile insulin syringes for drawing insulin from vials. The company sells these products through retail, hospital, pharmacy, and institutional channels to customers managing diabetes. The firm’s digital application, integrated with its physical products, supports diabetes management by assisting users in tracking and administering insulin. This complementary digital solution enhances the value of its device offerings, attracting both individual consumers and healthcare institutions seeking comprehensive diabetes care solutions. Embecta Corp. focuses on providing end-to-end solutions for people living with diabetes, leveraging its product range and digital tools to address key challenges in diabetes management. Embecta is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Embecta stock

EV/EBITDA (Enterprise Value to EBITDA) of Embecta is 5.30 in 2025.

EV/EBITDA (Enterprise Value to EBITDA) of Embecta changed from 10.80 to 5.30, representing a -50.93% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBITDA (Enterprise Value to EBITDA) Embecta since 2006 – with annual values, charts, and detailed analysis.

The EV/EBITDA ratio is a widely used valuation metric that compares a company's enterprise value to its EBITDA. It normalizes for differences in capital structure, taxation, and depreciation policies.

To evaluate EV/EBITDA (Enterprise Value to EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBITDA (Enterprise Value to EBITDA).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBITDA (Enterprise Value to EBITDA)'s Embecta with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Embecta

All Key Metrics — Embecta